Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Juli 2022

Genmab — Juli 2022

Planlagt Fastgjort Låst Flyttet Genmab
808 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #717

    Lol, you an old accountant or something? I grew up with an HP 28 haha, but as I am sitting next to the pool i have to use my own -small- brain 😉

    1 Reply Last reply
    0
    • D Offline
      D Offline
      deleted-user
      wrote on sidst redigeret af
      #718

      yeah a (young) old accountant with a degree in finance. Wow. An HP28 thats original. I guess that is just a bit more recent than the abacus Helge grew up with 😄 Enjoy the pool time. Over and out.

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #719

        that Hexelect article Peter posted earlier was reviewed by 2 Seagen employees https://www.nature.com/articles/s41587-022-01401-3 (behind a paywall)

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #720

          USA/lukning: Tunge aktiefald inden Fed-nyt og tech-regnskaber https://www.proinvestor.com/investornyt/855861/usa-lukning-tunge-aktiefald-inden-fed-nyt-og-tech-regnskaber

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #721

            Good old alemtuzumab targeted CD52 and made the same move as ofatumumab - from CLL to MS. But would be nice to see HexElect in action sooner than later

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #722

              Godmorgen. 🙂

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #723

                Godmorgen. 🙂

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Stroka
                  wrote on sidst redigeret af
                  #724

                  God morgen. 🙂

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #725

                    Aktier/tendens: Løftede kursmål til DSV forud for ventet grøn åbning https://www.proinvestor.com/investornyt/856102/aktier-tendens-loftede-kursmal-til-dsv-forud-for-ventet-gron-abning

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #726

                      Lidt mere om Rybrevant https://endpts.com/jj-looks-to-expand-rybrevant-lung-cancer-indication-to-larger-egfr-positive-population/

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #727

                        Bristol-Myers Squibb Salget af kræftbehandlingen Revlimid, som selskabet fik med i forbindelse med det 74 mia. dollar store opkøb af Celgene i 2019, faldt med 22 pct. til 2,50 mia. dollar, men slog alligevel analytikernes forventninger på 2,13 mia. dollar. https://www.proinvestor.com/investornyt/856232/bristol-myers-squibb-overgar-forventningerne-aktien-sendes-op

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #728

                          Mon Janssen spekulerer i at hæve prisen på Darzalex FasPro i takt med at billigere kopier af Revlimid vinder frem. Vi så jo i hvert fald Celgene hæve prisen markant de seneste år.

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #729

                            Det lyder plausibelt.

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              ProinvestorNEWS
                              wrote on sidst redigeret af
                              #730

                              USA/tendens: Efter fald tirsdag er der stigninger i vente onsdag https://www.proinvestor.com/investornyt/856290/usa-tendens-efter-fald-tirsdag-er-der-stigninger-i-vente-onsdag

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                ProinvestorNEWS
                                wrote on sidst redigeret af
                                #731

                                Onsdagens aktier: Novo i bund efter tirsdagens rekord i rødt marked
                                https://www.proinvestor.com/investornyt/856466/onsdagens-aktier-novo-i-bund-efter-tirsdagens-rekord-i-rodt-marked

                                1 Reply Last reply
                                0
                                • SolsenS Offline
                                  SolsenS Offline
                                  Solsen
                                  wrote on sidst redigeret af
                                  #732

                                  0,75% fra fed i dag.

                                  1 Reply Last reply
                                  0
                                  • J Offline
                                    J Offline
                                    JKY_VH
                                    wrote on sidst redigeret af
                                    #733

                                    helt som forventet

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #734

                                      Tecvayli: New Drug for Multiple Myeloma
                                      Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma. https://biopharma.media/tecvayli-new-drug-for-multiple-myeloma-5004/

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #735

                                        small sign of life of GEN1047 (DuoBody®-CD3xB7H4) https://www.clinicaltrials.gov/ct2/history/NCT05180474?A=2&B=3&C=merged#StudyPageTop . I COULD say 'they are ditching some indications' but I am gonna say 'they are focussing their efforts on the indications where they think it will work best'
                                        😉

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          peter12
                                          wrote on sidst redigeret af
                                          #736

                                          Lidt mere om hexelect https://www.bioworld.com/articles/521076-monoclonal-antibody-pairs-zipper-to-target-cancer

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper